|
St. Peter JV, Neafus KL, Khan MA, Vessey JT,
Lockheart MSK. Factors associated with the risk of liver enzyme elevation
in patients with type 2 diabetes treated with a thiazolidinedione. Pharmacotherapy.
2001;21(2):183-188.
|
